Hotspot DNA Methyltransferase 3A (DNMT3A) and Isocitrate Dehydrogenase 1 and 2 (IDH1/2) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for Immunotherapy
Nadine E. Struckman(Leiden University Medical Center), Marieke Griffioen(Leiden University Medical Center), Arnoud H. de Ru(Leiden University Medical Center), Rob C. M. de Jong(Leiden University Medical Center), Dyantha I. van der Lee(Leiden University Medical Center), Sophie-Anne I. Smith(Leiden University Medical Center), Georgia Koutsoumpli(Leiden University Medical Center), JH Falkenburg(Leiden University), Jan‐Henrik Mikesch(University Hospital Münster), M. Willy Honders(Leiden University Medical Center), Peter A. van Veelen(Leiden University Medical Center)
Cited by 6
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
|Journal of Clinical Investigation|2019|232
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
|Journal of Clinical Oncology|2024|204
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
|Blood|2020|137
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
|Molecular Therapy|2019|126